BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Bifidobacteria exert species-specific effects on constipation in BALB/c mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 8 Issue 10 Pages: 3587-3600 Pub: 2017 Oct 18 Epub: Authors Wang L , Hu L , Xu Q , Jiang T , Fang S , Wang G , Zhao J , Zhang H , Chen W , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 1 Pages: 375-393 Pub: 2019 Jan Epub: 2018 Oct 22 Authors Li Y , Lv L , Ye J , Fang D , Shi D , Wu W , Wang Q , Wu J , Yang L , Bian X , Jiang X , Jiang H , Yan R , Peng C , Li L , |
|
|
Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-?B activation through restoration of the disturbed gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 8 Pages: 4255-4265 Pub: 2018 Aug 15 Epub: Authors Kim WG , Kim HI , Kwon EK , Han MJ , Kim DH , |
|
|
Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-?B activation through restoration of the disturbed gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 8 Pages: 4255-4265 Pub: 2018 Aug 15 Epub: Authors Kim WG , Kim HI , Kwon EK , Han MJ , Kim DH , |
|
|
Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-?B activation through restoration of the disturbed gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 8 Pages: 4255-4265 Pub: 2018 Aug 15 Epub: Authors Kim WG , Kim HI , Kwon EK , Han MJ , Kim DH , |
|
|
Adhesive <i>Bifidobacterium</i> Induced Changes in Cecal Microbiome Alleviated Constipation in Mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1721 Pub: 2019 Epub: 2019 Aug 13 Authors Wang L , Chen C , Cui S , Lee YK , Wang G , Zhao J , Zhang H , Chen W , |
|
|
<i>Lactobacillus reuteri</i> NK33 and <i>Bifidobacterium adolescentis</i> NK98 alleviate <i>Escherichia coli</i>-induced depression and gut dysbiosis in mice. ✅
Go to Publication ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: Issue Pages: Pub: 2020 Apr 29 Epub: 2020 Apr 29 Authors Han SK , Kim JK , Joo MK , Lee KE , Han SW , Kim DH , |
|
|
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅
Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322 Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO , |
|
|
Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 9 Issue 1 Pages: 61-70 Pub: 2018 Jan 29 Epub: 2017 Oct 25 Authors Lau AS , Yanagisawa N , Hor YY , Lew LC , Ong JS , Chuah LO , Lee YY , Choi SB , Rashid F , Wahid N , Sugahara H , Xiao JZ , Liong MT , |
|
|
Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study. ✅
Nutrients (Nutrients ) Vol: 8 Issue 10 Pages: Pub: 2016 Oct 22 Epub: 2016 Oct 22 Authors Quagliariello A , Aloisio I , Bozzi Cionci N , Luiselli D , D'Auria G , Martinez-Priego L , Pérez-Villarroya D , Langerholc T , Primec M , Micetic-Turk D , Di Gioia D , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
